ENTRY       H00305                      Disease
NAME        Chancroid
DESCRIPTION Chancroid is a sexually transmitted disease (STD) caused by the gram-negative, short, slender bacterium Haemophilus ducreyi. It is a classical genito-ulcerative disease accompanied by inguinal lymphadenitis that is endemic in sub-Saharan Africa. It has generated considerable interest because it is associated as a co-factor for HIV transmission.
CATEGORY    Infectious disease
BRITE       Infectious diseases [BR:br08401]
             Bacterial infections
              Infections caused by other gamma proteobacteria
               H00305  Chancroid
            Human diseases in ICD-11 classification [BR:br08403]
             01 Certain infectious or parasitic diseases
              Predominantly sexually transmitted infections
               1A90  Chancroid
                H00305  Chancroid
PATHOGEN    Haemophilus ducreyi [GN:hdu]
            cytolethal distending toxin [KO:K11013 K11014 K11015]
DRUG        Tetracycline hydrochloride [DR:D02122]
            Doxycycline [DR:D00307]
            Doxycycline hyclate [DR:D02129]
            Doxycycline calcium [DR:D03903]
            Minocycline hydrochloride [DR:D00850]
            Streptomycin sulfate [DR:D01350]
            Demeclocycline hydrochloride [DR:D00290]
            Sulfadiazine [DR:D00587]
COMMENT     Pregnant women should be treated with either erythromycin or ceftriaxone regimens.
DBLINKS     ICD-11: 1A90
            ICD-10: A57
            MeSH: D002602
            MedlinePlus: 000635
REFERENCE   PMID:12576620
  AUTHORS   Lewis DA
  TITLE     Chancroid: clinical manifestations, diagnosis, and management.
  JOURNAL   Sex Transm Infect 79:68-71 (2003)
            DOI:10.1136/sti.79.3.228
REFERENCE   PMID:12653911
  AUTHORS   Sehgal VN, Srivastava G
  TITLE     Chancroid: contemporary appraisal.
  JOURNAL   Int J Dermatol 42:182-90 (2003)
            DOI:10.1046/j.1365-4362.2003.01724.x
REFERENCE   PMID:15918786
  AUTHORS   Annan NT, Lewis DA
  TITLE     Treatment of chancroid in resource-poor countries.
  JOURNAL   Expert Rev Anti Infect Ther 3:295-306 (2005)
            DOI:10.1586/14787210.3.2.295
///
